Skip to content
On this page:OverviewPublicationsKey papers
PICO Portalanswers from OpenAlex & ORCID

Taofeek K. Owonikoko

ResearcherPublications, citations & collaboration network

Taofeek K. Owonikoko is a researcher indexed in PICO Portal from OpenAlex & ORCID.

How many works does Taofeek K. Owonikoko have?

PICO Portalindexed works

Taofeek K. Owonikoko has 705 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Taofeek K. Owonikoko have?

PICO Portalcitation count

Taofeek K. Owonikoko has 58,750 citations in the OpenAlex counts PICO Portal stores.

What is the h-index of Taofeek K. Owonikoko?

PICO Portalh-index

Taofeek K. Owonikoko has an h-index of 88 in OpenAlex.

What is the i10-index of Taofeek K. Owonikoko?

PICO Portali10-index

Taofeek K. Owonikoko has an i10-index of 259 in OpenAlex.

What is the ORCID of Taofeek K. Owonikoko?

PICO Portalorcid

The ORCID for Taofeek K. Owonikoko is on the source record.

What is the OpenAlex record for Taofeek K. Owonikoko?

PICO Portalopenalex

The OpenAlex for Taofeek K. Owonikoko is on the source record.

What are the most-cited papers on Taofeek K. Owonikoko?

PICO Portalmost cited works
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers
Lori J. Wirth, Eric J. Sherman, Bruce Robinson, Benjamin Solomon, Hyunseok Kang, Jochen H. Lorch, Francis P. Worden, Marcia S. Brose, Jyoti D. Patel, Sophie Leboulleux, Yann Godbert, Fabrice Barlési, John C. Morris, Taofeek K. Owonikoko, Daniel S.W. Tan, Oliver Gautschi, Jared Weiss, Christelle de la Fouchardière, Mark E. Burkard, Janessa Laskin, Matthew H. Taylor, Matthias Kroiß, Jacques Médioni, Jonathan W. Goldman, Todd M. Bauer, Benjamin Levy, Viola W. Zhu, Nehal J. Lakhani, Víctor Moreno, Kevin Ebata, Michele Nguyen, Dana Heirich, Edward Y. Zhu, Xin Huang, Luxi Yang, Jennifer Kherani, S. Michael Rothenberg, Alexander Drilon, Vivek Subbiah, Manisha H. Shah, Maria E. Cabanillas
New England Journal of Medicine. 2020788 CitationsOPEN ACCESS
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
Myung‐Ju Ahn, Byoung Chul Cho, Enriqueta Felip, Ippokratis Korantzis, Kadoaki Ohashi, Margarita Majem, Óscar Juan, Sabin Handzhiev, Hiroki Izumi, Jong Seok Lee, Rafał Dziadziuszko, Jürgen Wolf, Fiona Blackhall, Martin Reck, Jean Bustamante Alvarez, Horst-Dieter Hummel, Anne‐Marie C. Dingemans, Jacob Sands, Hiroaki Akamatsu, Taofeek K. Owonikoko, Suresh S. Ramalingam, Hossein Borghaei, Melissa L. Johnson, Shuang Huang, Sujoy Mukherjee, Mukul Minocha, Tony Jiang, Pablo Martínez, Erik S. Anderson, Luis Paz‐Ares
New England Journal of Medicine. 2023526 CitationsOPEN ACCESS
Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer
M. Catherine Pietanza, Saiama N. Waqar, Lee M. Krug, Afshin Dowlati, Christine L. Hann, Alberto Chiappori, Taofeek K. Owonikoko, Kaitlin M. Woo, Robert J. Cardnell, Junya Fujimoto, Lihong Long, Lixia Diao, Jing Wang, Yevgeniva Bensman, Brenda Hurtado, Patricia M. de Groot, Erik P. Sulman, Ignacio I. Wistuba, Alice P. Chen, Martin Fleisher, John V. Heymach, Mark G. Kris, Charles M. Rudin, Lauren A. Byers
Journal of Clinical Oncology. 2018404 CitationsOPEN ACCESS

Related on PICO Portal

470M+ articles · 14-day free trial